These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23036334)

  • 1. Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy.
    Kivelä AJ; Knuuttila A; Räsänen J; Sihvo E; Salmenkivi K; Saarnio J; Pastorekova S; Pastorek J; Waheed A; Sly WS; Salo JA; Parkkila S
    Bioorg Med Chem; 2013 Mar; 21(6):1483-8. PubMed ID: 23036334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
    Capkova L; Koubkova L; Kodet R
    Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
    Ozensoy Guler O; Arslan O; Kockar F
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
    Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
    Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
    World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of carbonic anhydrase IX: a new strategy against cancer.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Anticancer Agents Med Chem; 2009 Jul; 9(6):693-702. PubMed ID: 19601749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium.
    Ananthanarayanan V; Tretiakova M; Husain AN; Krausz T; Antic T
    Am J Clin Pathol; 2014 Jul; 142(1):82-7. PubMed ID: 24926090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours.
    Hynninen P; Vaskivuo L; Saarnio J; Haapasalo H; Kivelä J; Pastoreková S; Pastorek J; Waheed A; Sly WS; Puistola U; Parkkila S
    Histopathology; 2006 Dec; 49(6):594-602. PubMed ID: 17163844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
    Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
    FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
    Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors.
    Innocenti A; Pastorekova S; Pastorek J; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5825-8. PubMed ID: 19751975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.